At Tenomix, our mission is to develop novel technologies that target inefficiencies in the pathology workflow, optimize cancer care and reduce healthcare costs. Our dedicated team of engineers, medical doctors, and clinical scientists is currently working on Tenomix’s flagship device, which autonomously searches for lymph nodes in resected cancer tissues and marks their locations for efficient extraction. This bench-top device replaces the existing tedious and unreliable manual lymph node finding process and greatly improves the speed and reliability of the cancer staging process. This enables clinicians to make better-informed treatment decisions, resulting in fewer patient complications and fatalities and ensures hospitals continuously meet their quality metrics.
Founders

Saumik Biswas
Co-Founder

Sherif Abdou
Co-Founder

Eveline Pasman
Co-Founder

Michael Lavdas
Co-Founder
Featured Stories

Innovative robot aims to revolutionize colorectal cancer staging accuracy
This article was first published on Waterloo News. Read the original article. Tenomix secures $2M in oversubscribed Canadian funding round to advance...

What impact did Collision have on Forge startups?
After two years of virtual events, numerous Forge startups attended Collision, North America’s fastest-growing technology conference, as it returned in-person...